Document Detail

Characterization of the behavior of alginate-based microcapsules in vitro and in vivo.
MedLine Citation:
PMID:  19761714     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: Functional formulations providing protection of nutritional products against gastric juice or a capable of delivering them to distinct areas of the gastrointestinal tract are increasingly utilized by the food industry. However, the application of functional excipients that are established in pharmaceutical applications is limited in case of food products, as they are typically not classified as Generally Recognized As Safe (GRAS). MATERIALS: Accordingly, we investigated whether two alginate-based microcapsule preparations (capsule diameter 1 - 2 mm) either based on alginate and maize starch (MS-type) or alginate and casein (OCF27-type) and both created from ingredients classified as food supplements provide functional properties with respect to regional gastrointestinal targeting. METHODS: For this purpose the in vitro disintegration and swelling of the microcapsules was tested in various media. Furthermore, individual microcapsules, magnetically labelled with 100 - 200 microg black iron oxide, were ingested by healthy volunteers under fasting and fed conditions. Gastrointestinal transit as well as the gastrointestinal disintegration behavior were determined by using Magnetic Marker Monitoring. RESULTS: The results of in vitro and in vivo investigations show that both types of microcapsules are resistant to gastric juice for approximately 10 hrs under fasting and fed conditions. However, the disintegration characteristics of the two types of microcapsules within the intestines are different. CONCLUSION: Whilst the MS-type of capsules disintegrated predominantly within the small intestine shortly after gastric emptying, the OCF27-type of capsules underwent a rather slow disintegration predominantly in the colon.
M Anschütz; G Garbacz; O Kosch; F Donath; J Wiedmann; W Hoeckh; L Trahms; B Schug; W Weitschies; H Blume
Related Documents :
12396464 - Development of an in vitro system simulating bucco-gastric digestion to assess the phys...
25213934 - Melatonin is synthesised by yeast during alcoholic fermentation in wines.
16024924 - Focus on the conditions of resection and reconstruction in gastric cancer. what extent ...
1797564 - Inhibition of food intake by omeprazole in the chicken.
21912674 - Evidence for time-of-day dependent effect of neurotoxic dorsomedial hypothalamic lesion...
23770904 - Study of the phenome(s) of salmonella typhimurium dt104 cultured from selected points a...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of clinical pharmacology and therapeutics     Volume:  47     ISSN:  0946-1965     ISO Abbreviation:  Int J Clin Pharmacol Ther     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-09-18     Completed Date:  2009-10-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9423309     Medline TA:  Int J Clin Pharmacol Ther     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  556-63     Citation Subset:  IM    
SocraTec R&D, Oberursel, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alginates / chemistry*
Chemistry, Pharmaceutical
Ferrosoferric Oxide / administration & dosage*,  pharmacokinetics*
Gastric Emptying / physiology
Gastrointestinal Transit / physiology
Hydrogen-Ion Concentration
Sex Characteristics
Stomach / physiology
Young Adult
Reg. No./Substance:
0/Alginates; 0/Capsules; 0/Excipients; 1317-61-9/Ferrosoferric Oxide; 9005-25-8/Starch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Meta-analysis of recent studies on patients admitted to hospital due to adverse drug effects.
Next Document:  Evaluation of the pharmacokinetic interaction between esomeprazole (40 mg) and acetylsalicylic acid ...